University of Texas Texas AM Investment Management Co. Boosts Holdings in HCA Healthcare, Inc. $HCA

University of Texas Texas AM Investment Management Co. raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 227.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 8,506 shares of the company’s stock after acquiring an additional 5,909 shares during the period. HCA Healthcare makes up approximately 0.6% of University of Texas Texas AM Investment Management Co.’s holdings, making the stock its 29th largest holding. University of Texas Texas AM Investment Management Co.’s holdings in HCA Healthcare were worth $3,971,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently modified their holdings of HCA. Palisade Asset Management LLC purchased a new position in HCA Healthcare during the 3rd quarter valued at about $26,000. Holos Integrated Wealth LLC purchased a new position in HCA Healthcare in the fourth quarter worth about $29,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth approximately $31,000. JPL Wealth Management LLC purchased a new stake in HCA Healthcare in the third quarter worth about $33,000. Finally, Aventura Private Wealth LLC purchased a new position in HCA Healthcare in the 4th quarter worth approximately $34,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $390.09 on Tuesday. The firm has a market capitalization of $86.54 billion, a P/E ratio of 13.41, a P/E/G ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The stock has a 50 day moving average price of $427.96 and a 200 day moving average price of $472.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. Royal Bank Of Canada cut their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Leerink Partners decreased their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Stephens lowered their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Deutsche Bank Aktiengesellschaft lowered their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday, April 28th. Finally, Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $506.14.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.